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Samiran Ray1 and Mark J. Peters1,2*See related research by van Paridon et al., http://www.ccforum.com/content/19/1/293We share the view of van Paridon et al. [1] that robust
data on fluid bolus therapy for sepsis resuscitation are
needed, and looked with interest to the Alberta Sepsis
Network’s recent report to add to our understanding.
We note that the authors chose to exclude children who
were expected to die <24 hours from presentation. We
would be grateful to know how many cases were
excluded on this basis. The majority of the hazard
from sepsis lies in this period. We recently defined
this risk in a similar cohort of children; 55 % of all
sepsis deaths (78 % of these being previously healthy
children) occurred within the first 24 hours [2].
Resuscitation interventions such as fluid and vasoactive
drugs are guided by changes in physiology. Inasmuch as* Correspondence: mark.peters@ucl.ac.uk
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(http://creativecommons.org/publicdomain/zephysiological variables are associated with mortality, these
interventions are also likely to have an immediate effect on
mortality. The authors suggest potential explanations for
the 1-year mortality effect seen with aggressive fluid admin-
istration: while all are not only plausible but likely, the effect
will only be seen if the acute phase is overcome. By exclud-
ing children dying early, the authors also reduce the poten-
tial to propensity match children receiving similar levels of
interventions. Pediatric Risk of Mortality (PRISM) scores
control for severity of illness, but information is lost given
that the PRISM score utilises categories of haemodynamic
variables rather than age-standardised continuous variables
[3]. We wonder whether the modest effect size difference
would persist with these alterations to the methodology.and Ari R JoffeWe thank Ray and Peters for their interest in our study.
They point out that we excluded children who were ex-
pected to die within 24 hours from presentation, and that
these are the children who may be most likely to benefit
from aggressive fluid resuscitation. They hypothesise that
aggressive fluid administration may be non-beneficial only
once the ‘acute phase’ is overcome.
We agree this is a limitation of our study. In our cohort
of children screened for sepsis in the paediatric ICU, one
child was excluded because survival for >24 hours was not
expected and one child was excluded because palliative
care had been decided upon. Although we do not have
exact numbers, the number of children with sepsispresenting to our Children’s Hospital emergency depart-
ment or referral area and dying before arriving in the
paediatric ICU is extremely small. In addition, although
only one patient in our cohort died in the paediatric ICU,
six children required ECLS (extracorporeal life-support),
an indicator of the severity of sepsis [4]. Thus, we believe
the number of patients excluded from our study who died
within 24 hours after sepsis presentation is very small. In
addition, we note that recent editorials continue to point
out the variability in fluid bolus therapy practice, the lim-
ited data on effectiveness of fluid bolus therapy and that
the ideal resuscitation target is a knowledge gap in sepsis
[5–7]. Although we do not recommend a change in prac-
tice at this time, we believe that further study of fluid
bolus therapy and alternative strategies for resuscitation in
sepsis are warranted.
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